{"name": "Stellar Biotechnologies",
 "permalink": "stellar-biotechnologies",
 "crunchbase_url": "http://www.crunchbase.com/company/stellar-biotechnologies",
 "homepage_url": "http://stellarbiotechnologies.com",
 "blog_url": "",
 "blog_feed_url": "http://feeds.feedburner.com/StellarBiotechnologiesNewsReleases",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 1999,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "KLHinfo@stellarbiotech.com",
 "phone_number": "1 805-488-2800",
 "description": "",
 "created_at": "Fri May 31 04:44:37 UTC 2013",
 "updated_at": "Fri May 31 04:44:37 UTC 2013",
 "overview": "\u003Cp\u003EStellar Biotechnologies, Inc. (OTCQB: SBOTF) (TSX-V: KLH) is the world leader in the development and sustainable manufacture of Keyhole Limpet Hemocyanin (KLH). We serve the growing demand for this essential molecule in pharmaceutical and immunodiagnostic markets.\u003C/p\u003E\n\n\u003Cp\u003EStellar Biotechnologies is committed to developing novel immune-based products for the treatment and assessment of cancer, infectious diseases and immune disorders. We revolutionized the environmentally sound production of KLH and have leveraged this expertise into a portfolio of Stellar KLH\u2122 products including carriers for vaccine conjugation, protein for immune stimulation, and novel assays. Stellar is expanding with its own proprietary therapeutic vaccine program.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       62],
      "assets/images/resized/0026/9553/269553v1-max-150x150.png"],
     [[181,
       76],
      "assets/images/resized/0026/9553/269553v1-max-250x250.png"],
     [[181,
       76],
      "assets/images/resized/0026/9553/269553v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$1.61M",
 "funding_rounds":
  [{"round_code": "seed",
    "source_url": "http://www.sec.gov/Archives/edgar/data/1540159/000154015913000003/xslFormDX01/primary_doc.xml",
    "source_description": "SEC",
    "raised_amount": 1613700.0,
    "raised_currency_code": "USD",
    "funded_year": 2013,
    "funded_month": 4,
    "funded_day": 11,
    "investments":
     []}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "332 East Scott Street",
    "address2": "",
    "zip_code": "93041 ",
    "city": "Port Hueneme",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        113],
       "assets/images/resized/0026/9552/269552v1-max-150x150.png"],
      [[250,
        188],
       "assets/images/resized/0026/9552/269552v1-max-250x250.png"],
      [[450,
        339],
       "assets/images/resized/0026/9552/269552v1-max-450x450.png"]],
    "attribution": null}],
 "external_links":
  []}